Quantum BioPharma Ltd. (NASDAQ:QNTM) — Market Cap & Net Worth
Market Cap & Net Worth: Quantum BioPharma Ltd. (QNTM)
Quantum BioPharma Ltd. (NASDAQ:QNTM) has a market capitalization of $22.08 Million ($22.08 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #24880 globally and #5296 in its home market, demonstrating a 12.34% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Quantum BioPharma Ltd.'s stock price $3.46 by its total outstanding shares 6398605 (6.40 Million). Also see Quantum BioPharma Ltd. total assets for a full breakdown of the balance sheet.
Quantum BioPharma Ltd. Market Cap History: 2018 to 2026
Quantum BioPharma Ltd.'s market capitalization history from 2018 to 2026. Data shows change from $17.89 Billion to $22.14 Million (-50.29% CAGR). Also see QNTM operating cash flow for how efficiently the company converts equity into cash flow.
Index Memberships
Quantum BioPharma Ltd. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.00% | #706 of 976 |
Weight: Quantum BioPharma Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Quantum BioPharma Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Quantum BioPharma Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check QNTM live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of QNTM by Market Capitalization
Companies near Quantum BioPharma Ltd. in the global market cap rankings as of September 18, 2026. Review Quantum BioPharma Ltd. (QNTM) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Quantum BioPharma Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.87 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #337 globally with a market cap of $79.84 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $60.95 Billion USD ( AU$86.14 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #504 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.87 Billion | $516.34 |
| #337 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.84 Billion | $789.45 |
| #455 | CSL Ltd | AU:CSL | $60.95 Billion | AU$177.56 |
| #504 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $158.07 |
Quantum BioPharma Ltd. Historical Marketcap From 2018 to 2026
Between 2018 and today, Quantum BioPharma Ltd.'s market cap moved from $17.89 Billion to $ 22.14 Million, with a yearly change of -50.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $22.14 Million | -52.60% |
| 2025 | $46.71 Million | +98.37% |
| 2024 | $23.55 Million | -93.85% |
| 2023 | $382.64 Million | +16.75% |
| 2022 | $327.74 Million | -22.75% |
| 2021 | $424.23 Million | -34.62% |
| 2020 | $648.82 Million | -71.27% |
| 2019 | $2.26 Billion | -87.38% |
| 2018 | $17.89 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Quantum BioPharma Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.08 Million USD |
| MoneyControl | $22.08 Million USD |
| MarketWatch | $22.08 Million USD |
| marketcap.company | $22.08 Million USD |
| Reuters | $22.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Quantum BioPharma Ltd.
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in d… Read more